| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
0.0078 |
1 |
? － ? |
Rifampicin (Rifampin)  |
1082 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
1 |
8 |
0.25 － 16 |
DC-159a |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
1 |
32 |
0.25 － 32 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
1 |
32 |
0.25 － 128 |
Gemifloxacin |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
2 |
32 |
0.5 － 64 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
>8 |
>128 |
4 － >128 |
Levofloxacin (Levaquin, Quixin) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-resistant) |
>32 |
>64 |
8 － >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-susceptible) |
0.015 |
0.03 |
0.008 － 0.03 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-susceptible) |
0.03 |
0.03 |
0.008 － 0.06 |
Gemifloxacin |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-susceptible) |
0.03 |
0.06 |
0.015 － 0.06 |
DC-159a |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-susceptible) |
0.03 |
0.06 |
0.015 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Staphylococcus aureus (methicillin-resistant + quinolone-susceptible) |
0.25 |
0.25 |
0.12 － 0.5 |
Levofloxacin (Levaquin, Quixin) |
268 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate) |
0.5 |
2 |
0.25 － 2 |
RWJ-416457 |
189 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate) |
1 |
4 |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate) |
4 |
8 |
2 － 8 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate) |
>32 |
>32 |
4 － >32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
189 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate-resistant) |
- |
- |
2 － ? |
Microbisporicin |
801 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate-resistant) |
- |
- |
8 － ? |
Nisin |
801 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate-resistant) |
- |
- |
>128 － ? |
Actagardine |
801 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate-resistant) |
- |
- |
128 － ? |
Mersacidin |
801 |
| Staphylococcus aureus (methicillin-resistant + vancomycin-intermediate-resistant) |
- |
- |
>128 － ? |
Planosporicin |
801 |
| Staphylococcus aureus (methicillin-resistant) |
0.0078 |
0.0078 |
? － ? |
Rifampicin (Rifampin) |
1082 |
| Staphylococcus aureus (methicillin-resistant) |
0.0078 |
0.016 |
? － ? |
Rifalazil (ABI-1648, KRM-1648) |
1082 |
| Staphylococcus aureus (methicillin-resistant) |
0.008 |
0.008 |
0.004 － 0.5 |
Rifampicin (Rifampin) |
410 |
| Staphylococcus aureus (methicillin-resistant) |
0.008 |
0.015 |
0.002 － 0.125 |
API-1252 |
169 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.015 |
≤0.008 － >128 |
Rifampicin (Rifampin) |
178 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.03 |
0.008 － 0.03 |
BC-7013 |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.03 |
0.015 － 0.03 |
PD 124816 |
248 |